Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria

Artemisinin-based combination therapies are recommended as first-line agents for treating uncomplicated Plasmodium falciparum malaria. Ferroquine, a 4-aminoquinolone, is a novel long-acting combination partner for fast-acting drugs like artesunate (AS). We did a small phase 2a, multicenter, open-lab...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Trop Med Hyg
Hoofdauteurs: Supan, Christian, Mombo-Ngoma, Ghyslain, Kombila, Maryvonne, Ospina Salazar, Carmen L., Held, Jana, Lell, Bertrand, Cantalloube, Cathy, Djeriou, Elhadj, Ogutu, Bernhards, Waitumbi, John, Otsula, Nekoye, Apollo, Duncan, Polhemus, Mark E., Kremsner, Peter G., Walsh, Douglas S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The American Society of Tropical Medicine and Hygiene 2017
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544076/
https://ncbi.nlm.nih.gov/pubmed/28722611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.16-0731
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items